Recovery time constant in central nervous system O-2 toxicity in the rat

被引:20
作者
Arieli, R
Gutterman, A
机构
[1] Israel Naval Medical Institute, IDF Medical Corps, Haifa 31080
关键词
high pressure oxygen; intermittent exposure; electroencephalogram;
D O I
10.1007/s004210050145
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The development of oxygen toxicity can be delayed by intermittent periods of normoxia. However, there is no accepted procedure for quantifing the recovery during normoxia. A cumulative oxygen toxicity index - K, when Kreaches a critical value (K-c) and the toxic effect is manifested, can be calculated using the equation K = t(e)(2) x PO2c where t(e) is hyperoxic exposure time and PO2 is oxygen pressure and c is a power parameter. Recovery during normoxia (reducing K) is is calculated by the equation K-2 = K-1 x e(-rtr) where t(r) is recovery time, r being the recovery time constant. A combination of accumulation of oxygen toxicity and its recovery can be used to calculate central nervous system oxygen toxicity. In protocol A (n = 25), r was calculated for rats exposed either continuously to 608 kPa oxygen or to PO2 = 608 kPa followed by a period of normoxia (3.5% O-2), with a subsequent return to PO2 = 608 kPa until appearance of the first electrical discharge (FED) in the electroencephalogram which precedes clinical convulsions. In protocol B (n = 22), predicted latency to the FED was compared to measured latency for seven different exposures to hyperbaric oxygen (HBO), followed by a period of normoxia and further HBO exposure. Recovery followed an exponential path, with r = 0.31 (SD 0.12) min(-1). The predicted latency to FED in protocol B correlated with the measured latencies. Calculation of the recovery of the CNS oxygen toxicity agreed with the previously suggested exponential recovery-of the hypoxic ventilatory response and was probably a general recovery process. We concluded that recovery can be applied to the design of various hyperoxic exposures.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 14 条
  • [11] LAMBERTSEN CJ, 1989, PULMONARY TOLERANCE
  • [12] LAVY S, 1973, AEROSPACE MED, V44, P254
  • [13] TORBATI D, 1995, CENTRAL NERVOUS SYST, P8
  • [14] WAISMAN D, 1992, AVIAT SPACE ENVIR MD, V63, P280